Interleukin-10 Improves Outcome and Alters Proinflammatory Cytokine Expression after Experimental Traumatic Brain Injury
Authors:
- Alan I. FadenAFAlan I. Faden
Open Access
- 1 September 1998
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 153 (1) , 143-151
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Differential effects of Th1 and Th2 derived cytokines on NGF synthesis by mouse astrocytesFEBS Letters, 1996
- Tumor necrosis factor-α-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic windowBrain Research, 1995
- Two inhibitors of pro‐inflammatory cytokine release, interleukin‐10 and interleukin‐4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytesEuropean Journal of Immunology, 1994
- Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation.Journal of Experimental Medicine, 1994
- The Early Reactions of Non-Neuronal Cells to Brain InjuryAnnual Review of Neuroscience, 1994
- Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein.Journal of Clinical Investigation, 1994
- Blood-brain barrier changes following intracerebral injection of human recombinant tumor necrosis factor-? in the ratJournal of Neuro-Oncology, 1994
- Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.Journal of Experimental Medicine, 1993
- Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.Journal of Experimental Medicine, 1991
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976